|
|
||||||||

Hospital Professor Edgard Santos, Universidade Federal da Bahia, Bahia, Brasil
The treatment of two patients with severe mucosal leishmaniasis due to Leishmania braziliensis braziliensis is described. Both patients had received much prior antimonial therapy and one had relapsed after a total dose of 2.5 g of Amphotericin B. Both patients responded to prolonged continuous Pentostam therapy at a daily dose of 20 mg Sbv/kg/day for 62 days in one case and for 85 days in the other. Pentavalent antimonials can be curative in such protracted courses in selected patients unresponsive to standard chemotherapy.
Accepted for publication February 22, 1985.
This article has been cited by other articles:
![]() |
A. O. de Souza, F. P. Hemerly, A. C. Busollo, P. S. Melo, G. M. C. Machado, C. C. Miranda, R. M. Santa-Rita, M. Haun, L. L. Leon, D. N. Sato, et al. 3-[4'-Bromo-(1,1'-biphenyl)-4-yl]-N,N-dimethyl-3-(2-thienyl)-2-propen-1-amine: synthesis, cytotoxicity, and leishmanicidal, trypanocidal and antimycobacterial activities J. Antimicrob. Chemother., November 1, 2002; 50(5): 629 - 637. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |